3D Signatures Inc. Announces Successful Scoring Model Development and Analytical Validation of the Telo-HL(TM) Test for Hodgkin’s Lymphoma Genetics Investing
MediciNova Announces Collaboration with the University of Sydney Concord Cancer Centre Pharmaceutical Investing
MediciNova Announces Results of Phase 2 Clinical Trial of MN-166 (ibudilast) in Methamphetamine Dependence Biotech Investing
Catalyst Pharmaceuticals Announces Submission of New Drug Application for Firdapse Pharmaceutical Investing
Galectin Therapeutics Reports 2017 Financial Results and Provides Business Update Pharmaceutical Investing
Insmed Submits New Drug Application to FDA for ALIS in NTM Lung Disease Caused by MAC Pharmaceutical Investing
